Published in J Clin Pathol on April 01, 1994
Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J Exp Med (2005) 2.18
Dry eye as a mucosal autoimmune disease. Int Rev Immunol (2013) 1.85
NGcGM3 ganglioside: a privileged target for cancer vaccines. Clin Dev Immunol (2010) 1.21
Caveolins: targeting pro-survival signaling in the heart and brain. Front Physiol (2012) 0.89
Anti-GM1 antibodies in polyneuropathies of unknown origin. J Clin Pathol (1996) 0.78
Alteration of CD1 expression in multiple sclerosis. Clin Exp Immunol (2012) 0.76
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol (1988) 2.12
The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology (1990) 1.87
Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve (1991) 1.63
Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasia. Ann Neurol (1989) 1.55
Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia (1989) 1.32
Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol (1992) 1.23
Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol (1990) 1.21
Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera. J Neuroimmunol (1991) 1.20
First international symposium on Sjögren's syndrome: suggested criteria for classification. Scand J Rheumatol Suppl (1986) 1.16
Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology (1988) 1.16
Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients. J Clin Invest (1980) 1.14
Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. J Immunol (1984) 1.12
Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease. Neurology (1988) 1.06
Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve. Neurology (1993) 0.94
Possible immunoregulatory role for CD5 + B cells. Clin Immunol Immunopathol (1990) 0.93
Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy. J Neuroimmunol (1989) 0.85
Ganglioside antibodies: a lack of diagnostic specificity and clinical utility? J Neurol (1992) 0.80
A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia (1993) 4.43
Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care (1999) 3.27
Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry (1988) 3.04
A feasibility study of the use of continuous subcutaneous insulin infusion in a diabetic clinic: patients' choice of treatment. Diabet Med (1984) 2.84
Predicting risk of diabetic ketoacidosis in patients using continuous subcutaneous insulin infusion. Br Med J (Clin Res Ed) (1986) 2.79
Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care (2001) 2.60
Phosphatidate accumulation in hormone-treated hepatocytes via a phospholipase D mechanism. J Biol Chem (1987) 2.40
The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia (1992) 2.38
Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet (1999) 2.37
The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care (1994) 2.36
Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia (1993) 2.05
The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med (2001) 1.91
Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care (2001) 1.82
Severe hyperkalaemia and ketoacidosis during routine treatment with an insulin pump. Br Med J (Clin Res Ed) (1985) 1.62
Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting--randomised clinical study subset data. Aliment Pharmacol Ther (2011) 1.62
Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care (1983) 1.61
Increased Langerhan cell density and corneal nerve damage in diabetic patients: role of immune mechanisms in human diabetic neuropathy. Cont Lens Anterior Eye (2010) 1.61
A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J (2001) 1.59
The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med (1996) 1.56
The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med (1994) 1.53
The tactile circumferential discriminator. A new, simple screening device to identify diabetic patients at risk of foot ulceration. Diabetes Care (1997) 1.42
Aetiopathogenesis and management of impotence in diabetic males: four years experience from a combined clinic. Diabet Med (1995) 1.41
The relationship of static foot structure to dynamic foot function. J Biomech (1997) 1.40
Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol (1995) 1.40
Phosphatidate-dependent protein phosphorylation. Proc Natl Acad Sci U S A (1991) 1.39
Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly. J Clin Endocrinol Metab (1996) 1.39
Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care (1991) 1.39
Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care (1998) 1.37
Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis (1998) 1.36
A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care (2001) 1.34
Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia (1989) 1.32
Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract (1991) 1.32
Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care (1983) 1.29
Automatic analysis of diabetic peripheral neuropathy using multi-scale quantitative morphology of nerve fibres in corneal confocal microscopy imaging. Med Image Anal (2011) 1.29
Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting? Diabetologia (1982) 1.25
Ca2+-mobilizing hormones elicit phosphatidylethanol accumulation via phospholipase D activation. FEBS Lett (1987) 1.25
A measure of treatment satisfaction designed specifically for people with insulin-dependent diabetes. Diabet Med (1988) 1.24
Current perception thresholds: a new, quick, and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia (1989) 1.23
Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia (2001) 1.20
Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol (2001) 1.19
Diabetic neuropathy. Med Clin North Am (1998) 1.18
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia (1996) 1.17
Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot. Diabetes Care (2001) 1.16
Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract (1998) 1.16
Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care (1995) 1.16
Anaphylactoid reaction to oxytocin in pregnancy. Anaesthesia (1985) 1.13
Diabetic thoracic polyradiculopathy presenting as abdominal swelling. Br Med J (Clin Res Ed) (1984) 1.12
Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med (1994) 1.12
Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med (1999) 1.11
Gait abnormalities in diabetic neuropathy. Diabetes Care (1997) 1.10
Retinal nerve fibre layer thinning associated with diabetic peripheral neuropathy. Diabet Med (2012) 1.10
Psychological status of diabetic people with or without lower limb disability. Diabetes Res Clin Pract (1996) 1.10
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer. Int J Cancer (2000) 1.09
The hormone-sensitive hepatic Na+-pump. Evidence for regulation by diacylglycerol and tumor promoters. J Biol Chem (1986) 1.09
Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus. Clin Exp Immunol (1992) 1.08
Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes (1994) 1.08
Do people with diabetes wear their prescribed footwear? Diabet Med (1996) 1.08
Antiphospholipid antibodies and Mycoplasma pneumoniae infection. Postgrad Med J (1990) 1.07
Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study. Diabetes Care (1994) 1.06
The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population. Diabetes Care (1985) 1.06
Sural nerve oxygen tension in diabetes. Br Med J (Clin Res Ed) (1986) 1.06
Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care (1993) 1.06
Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care (1999) 1.06
Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol (2000) 1.05
Angioedema responding to antiprotease treatment but without abnormalities of the complement system. Clin Allergy (1980) 1.05
The Neurometer: validation and comparison with conventional tests for diabetic neuropathy. Diabet Med (1991) 1.05
The natural history of painful diabetic neuropathy--a 4-year study. Postgrad Med J (1983) 1.04
Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care (1994) 1.03
Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. Postgrad Med J (1994) 1.03
TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis. Int J Cancer (1999) 1.03
Lack of knowledge of symptoms of hypoglycaemia by elderly diabetic patients. Age Ageing (1991) 1.03
Failure of delayed hypersensitivity skin testing to predict postoperative sepsis and mortality. Br Med J (Clin Res Ed) (1982) 1.03
The clinical diagnosis of sensory neuropathy in elderly people. Diabet Med (1993) 1.02
Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy. J Cell Mol Med (2005) 1.02
The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1. Diabetologia (1999) 1.02
The Neuropad test: a visual indicator test for human diabetic neuropathy. Diabetologia (2008) 1.01
A foot care program for diabetic unilateral lower-limb amputees. Diabetes Care (2001) 1.01
Under-reporting of antibiotic anaphylaxis may put patients at risk. Lancet (1999) 1.00
Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy. Clin Sci (Lond) (2000) 0.98
Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions. Curr Cardiol Rev (2012) 0.98
Continuous activity monitoring in persons at high risk for diabetes-related lower-extremity amputation. J Am Podiatr Med Assoc (2001) 0.97
Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. Immunology (1993) 0.96
Hypoxic neuropathy: relevance to human diabetic neuropathy. Diabetologia (1990) 0.96
Serum levels of the TGF-beta receptor are increased in atherosclerosis. Atherosclerosis (1996) 0.95
Studies of chemotaxis of lymphocytes. Agents Actions (1976) 0.95
The effect of callus removal on dynamic plantar foot pressures in diabetic patients. Diabet Med (1992) 0.95
Association of apolipoprotein epsilon2 allele with diabetic nephropathy in Caucasian subjects with IDDM. Diabetes (1998) 0.95
Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage? Diabetologia (1987) 0.95
Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia (1993) 0.94
Endoneurial capillary abnormalities in mild human diabetic neuropathy. J Neurol Neurosurg Psychiatry (1992) 0.94
Gm allotypes in membranous nephropathy. N Engl J Med (1983) 0.94
Dual-model automatic detection of nerve-fibres in corneal confocal microscopy images. Med Image Comput Comput Assist Interv (2010) 0.94
The significance of CD105, TGFbeta and CD105/TGFbeta complexes in coronary artery disease. Atherosclerosis (2000) 0.94
An analysis of dynamic forces transmitted through the foot in diabetic neuropathy. Diabetes Care (1998) 0.93
Use of plaster casts in the management of diabetic neuropathic foot ulcers. Diabetes Care (1986) 0.93
Evidence for circulating complexes containing IgE in patients with atopic dermatitis. Int Arch Allergy Appl Immunol (1985) 0.92
Observations on severe ulnar neuropathy in diabetes. J Diabetes Complications (1998) 0.92